BOSTON SCIENTIFIC CORPORATION Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination
BOSTON SCIENTIFIC CORPORATION (BSX) reported Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination of $391.00 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-29.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree
us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1 · last filed 2018-10-29
- BOSTON SCIENTIFIC CORPORATION business combination, consideration transferred, including equity interest in acquiree held prior to combination for the quarter ending 2018-09-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION business combination, consideration transferred, including equity interest in acquiree held prior to combination for the quarter ending 2014-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION business combination, consideration transferred, including equity interest in acquiree held prior to combination for fiscal 2014 was $510.00M.
| Period end | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 3 month | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 6 month | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 9 month | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $391.00M 10-Q · filed 2018-10-29 | ||
| 2018-06-30 | $391.00M 10-Q · filed 2018-07-31 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $510.00M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $510.00M 10-Q · filed 2014-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |